By putting our cutting-edge research to use in clinical studies and novel technologies, we collaborate to advance scientific understanding. In partnership, we can co-develop innovations that take us all further, faster.
The UCL Division of Psychiatry, part of UCL Brain Sciences, is working with startup Tend VR. Together, we are exploring how technology could help reach more people living with anxiety and depression.
The UCL and Eisai partnership seeks to discover novel therapeutics for neurological diseases. The first drug candidate to result from their joint research, E2814, has been selected for a new trial.
Close
